HomeDYN • NASDAQ
add
Dyne Therapeutics Inc
Previous close
$13.99
Day range
$14.03 - $15.01
Year range
$6.36 - $47.45
Market cap
1.67B USD
Avg Volume
2.41M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 122.37M | 76.95% |
Net income | -115.36M | -75.72% |
Net profit margin | — | — |
Earnings per share | -1.05 | -29.63% |
EBITDA | -121.87M | -77.21% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 677.49M | 49.38% |
Total assets | 721.07M | 38.06% |
Total liabilities | 52.10M | 17.81% |
Total equity | 668.97M | — |
Shares outstanding | 113.67M | — |
Price to book | 2.38 | — |
Return on assets | -43.32% | — |
Return on capital | -45.45% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -115.36M | -75.72% |
Cash from operations | -105.89M | -34.83% |
Cash from investing | 1.46M | 100.81% |
Cash from financing | 141.24M | -65.41% |
Net change in cash | 36.81M | -75.46% |
Free cash flow | -67.58M | 15.75% |
About
Founded
2017
Headquarters
Website
Employees
192
